Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

E3 Ubiquitin-Proteinligase CBL

Das CBL-Gen kodiert ein Ubiquitin und ist damit für die Degradation von Proteinen verantwortlich. Es wird als Proto-Onkogen bezeichnet und Mutationen führen zu einem autosomal dominanten Noonan-Syndrom ähnlichen Krankheitsbild und juvenile myelomonozytische Leukämie.

Gentests:

Klinisch Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Forschung Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Noonan-Syndrom ähnliches Krankheitsbild und juvenile myelomonozytische Leukämie
CBL

Referenzen:

1.

Veiga E et al. (2005) Listeria hijacks the clathrin-dependent endocytic machinery to invade mammalian cells.

external link
2.

Martin HC et al. (2014) Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis.

external link
3.

Rathinam C et al. (2010) c-Cbl deficiency leads to diminished lymphocyte development and functions in an age-dependent manner.

external link
4.

Sanada M et al. (2009) Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.

external link
5.

Dragone LL et al. (2006) Src-like adaptor protein (SLAP) regulates B cell receptor levels in a c-Cbl-dependent manner.

external link
6.

Molero JC et al. (2004) c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action.

external link
7.

Nau MM et al. (2003) Comparative genomic organization of the cbl genes.

external link
8.

Fu JF et al. (2003) Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia.

external link
9.

Naramura M et al. (2002) c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation.

external link
10.

Petrelli A et al. (2002) The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met.

external link
11.

Soubeyran P et al. (2002) Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors.

external link
12.

Thien CB et al. (2001) RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation.

external link
13.

Baumann CA et al. (2000) CAP defines a second signalling pathway required for insulin-stimulated glucose transport.

external link
14.

Joazeiro CA et al. (1999) The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.

external link
15.

Yoon CH et al. (1995) Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl.

external link
16.

Shen Y et al. (2000) InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase.

external link
17.

Loh ML et al. (2009) Mutations in CBL occur frequently in juvenile myelomonocytic leukemia.

external link
18.

Muramatsu H et al. (2010) Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia.

external link
19.

Pérez B et al. (2010) Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia.

external link
20.

Pathak A et al. (2015) Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family.

external link
21.

Martinelli S et al. (2010) Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype.

external link
22.

Niemeyer CM et al. (2010) Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia.

external link
23.

Savage PD et al. (1991) Relationship of the human protooncogene CBL2 on 11q23 to the t(4;11), t(11;22), and t(11;14) breakpoints.

external link
24.

Wei S et al. (1990) Physical mapping of the human chromosome 11q23 region containing the ataxia-telangiectasia locus.

external link
25.

Langdon WY et al. (1989) v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas.

external link
26.

Mastick CC et al. (1995) Insulin stimulates the tyrosine phosphorylation of caveolin.

external link
27.

Jones C et al. (1995) Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2.

external link
28.

Jones C et al. (1994) Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3.

external link
29.

Orphanet article

Orphanet ID 242915 external link
30.

NCBI article

NCBI 867 external link
31.

OMIM.ORG article

Omim 165360 external link
Update: 14. August 2020
Copyright © 2005-2024 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz | Impressum